IHH Healthcare announced on Nov 24 that it constantly reviews and assesses the strategic direction of IHH Group’s investments. "In relation to IHH Group’s investments in China, there have been discussions on the strategic directions but no definitive decisions have been made as at the date of this announcement. Any proposals with regard to IHH Group’s investment in any subsidiaries would have to be considered and decided by the Board of Directors of IHH and/or its relevant subsidiaries," IHH said.
The announcement was in response to a Bloomberg article that said IHH was considering the sale of its Chinese assets for as much as US$1 billion  which was reproduced in the Malaysian media.